TREM1 rs2234237 (Thr25Ser) Polymorphism in Patients with Cutaneous Leishmaniasis Caused by Leishmania guyanensis: A Case-Control Study in the State of Amazonas, Brazil
Authors:
- José Do Espírito Santo JúniorJJJosé Do Espírito Santo Júnior
- Tirza Gabrielle Ramos de MesquitaTMTirza Gabrielle Ramos de Mesquita
- Luan Diego Oliveira da SilvaLSLuan Diego Oliveira da Silva
- Felipe Jules de AraújoFAFelipe Jules de Araújo
- Josué Lacerda de SouzaJSJosué Lacerda de Souza
- Thaís Carneiro de LacerdaTLThaís Carneiro de Lacerda
- Lener Santos da SilvaLSLener Santos da Silva
- Cláudio Marcello da Silveira JúniorCJCláudio Marcello da Silveira Júnior
- Krys Layane Guimarães Duarte QueirozKQKrys Layane Guimarães Duarte Queiroz
- Diogo Matos dos SantosDSDiogo Matos dos Santos
- Cilana Chagas da SilvaCSCilana Chagas da Silva
- Héctor David Graterol SequeraHSHéctor David Graterol Sequera
Open Access
Abstract
Background: Leishmaniasis is an infectious disease caused by Leishmania parasites. A Th1 immune response is necessary in the acute phase to control the pathogen. The triggering receptor expressed on myeloid cells (TREM)-1 is a potent amplifier of inflammation. Our aim is to identify whether the TREM1 variant rs2234237 A/T (Thr25Ser) is associated with the disease development of cutaneous leishmaniasis (CL) in Leishmania guyanensis-infected individuals. The effects of the rs2234237 genotypes on plasma cytokines IL-1β, IL-6, IL-8, IL-10, MCP-1 and TNF-α are also investigated. Methods: 838 patients with CL and 818 healthy controls (HCs) living in the same endemic areas were genotyped by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism. Plasma cytokines were assayed in 400 patients with CL and 400 HCs using the BioPlex assay. Results: The genotypes’ and alleles’ frequencies were similar in both patients with CL (AA = 618, 74%; AT = 202, 24%; TT = 18, 2%) and in HCs (AA = 580, 71%; AT = 220, 27%; TT = 18, 2%). Rs2234237 showed a modest effect on plasma IL-10 that disappeared when correction of the p-value was applied. Plasma IL-10 by rs2234237 genotypes were (mean ± SEM; AA = 2.91 pg/mL ± 0.14; AT = 2.35 pg/mL ± 0.12; TT = 3.14 pg/mL ± 0.56; p = 0.05). Conclusion: The TREM1 rs2234237 (Thr25Ser) seems to have no influence on the susceptibility or resistance to L. guyanensis infections.Keywords
Funding Information
- Brazilian Council for Scientific and Technological Development (CNPq) (404181/2012-0)
- Fundação de Amparo e Pesquisa do Estado Amazonas (06201954/2015)
This publication has 42 references indexed in Scilit:
- Perioperative Dynamics of TLR2, TLR4, and TREM-1 Expression in Monocyte Subpopulations in the Setting of On-Pump Coronary Artery Bypass SurgeryISRN Inflammation, 2013
- Triggering receptor expressed on myeloid cells − 1 (Trem-1) on blood neutrophils is associated with cytokine inducibility in human E. coli sepsisDiagnostic Pathology, 2013
- A TREM-1 Polymorphism A/T within the Exon 2 Is Associated with Pneumonia in Burn-Injured PatientsISRN Inflammation, 2013
- TREM-1 Amplifies Corneal Inflammation after Pseudomonas aeruginosa Infection by Modulating Toll-Like Receptor Signaling and Th1/Th2-Type Immune ResponsesInfection and Immunity, 2011
- fdrtool: a versatile R package for estimating local and tail area-based false discovery ratesBioinformatics, 2008
- Functional genomics of silencing TREM-1 on TLR4 signaling in macrophagesAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Effects of TREM-1 activation in human neutrophils: activation of signaling pathways, recruitment into lipid rafts and association with TLR4International Immunology, 2006
- Requirements for Th1-dependent immunity against infection with Leishmania majorMicrobes and Infection, 2004
- Culture-Independent Species Typing of Neotropical Leishmania for Clinical Validation of a PCR-Based Assay Targeting Heat Shock Protein 70 GenesJournal of Clinical Microbiology, 2004
- The immunology of susceptibility and resistance to Leishmania major in miceNature Reviews Immunology, 2002